Blood Brain Barrier & Cytokines

Cytokines can affect the central nervous system through crossing the blood brain barrier and entering the CSF and interstitial fluid spaces. Some cytokines are able to cross through transport systems and can affect tissues within the CNS, whereas others are unable to cross. Here is the latest research on the blood brain barrier and cytokines.

July 1, 2020
Open Access

Acute Neurofilament Light Chain Plasma Levels Correlate With Stroke Severity and Clinical Outcome in Ischemic Stroke Patients

Frontiers in Neurology
Helle H NielsenKate L Lambertsen
June 26, 2020
Review
Open Access

Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies

Frontiers in Physiology
Hannah ChewAlfred N Fonteh
June 30, 2020
Preprint
Open Access

Increased serum peripheral C-reactive protein is associated with reduced small-molecule brain perfusion in healthy volunteers and subjects with major depressive disorder

MedRxiv : the Preprint Server for Health Sciences
Federico TurkheimerM. Veronese
June 24, 2020

Tizoxanide mitigates inflammatory response in LPS-induced neuroinflammation in microglia via restraining p38/MAPK pathway

European Review for Medical and Pharmacological Sciences
X-W LiZ-F Ruan
June 26, 2020
Open Access

An Experimental Investigation of White Matter Venous Hemodynamics: Basic Physiology and Disruption in Neuroinflammatory Disease

Frontiers in Neurology
Scott C KolbeTrevor J Kilpatrick
July 2, 2020

Research progress of mechanisms for tight junction damage on blood-brain barrier inflammation

Archives of Physiology and Biochemistry
Bo ZhaoYunman Li
July 2, 2020
Review
Open Access

Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS)

International Journal of Molecular Sciences
Mirre De BondtSofie Struyf
July 1, 2020

Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors

Multiple Sclerosis and Related Disorders
Ziliotto NicoleBernardi Francesco
July 1, 2020

Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury

Nanomedicine : Nanotechnology, Biology, and Medicine
Karthick MayilsamySubhra Mohapatra
July 1, 2020

Quercetin protects against cerebral ischemia/reperfusion and oxygen glucose deprivation/reoxygenation neurotoxicity

The Journal of Nutritional Biochemistry
Ya-Yu WangChun-Jung Chen
July 9, 2020
Review
Open Access

Zonulin-Dependent Intestinal Permeability in Children Diagnosed with Mental Disorders: A Systematic Review and Meta-Analysis

Nutrients
Birna AsbjornsdottirBryndis Eva Birgisdottir

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/blood-brain-barrier-cytokines/177d3517-977b-435c-852d-c7d365bb7903